Related Experiment Video
Updated: Apr 13, 2026
Solubilization and Bio-conjugation of Quantum Dots and Bacterial Toxicity Assays by Growth Curve and Plate Count
Published on: July 11, 2012
Microwave-Assisted Synthesized ZnO@APTES Quantum Dots Exhibits Potent Antibacterial Efficacy Against
Fangyuan Du1, Jingqi Niu1, Yu Hong1
1Key Laboratory of Livestock Infectious Diseases, Ministry of Education, and Key Laboratory of Ruminant Infectious Disease Prevention and Control (East), Ministry of Agriculture and Rural Affairs, College of Animal Science and Veterinary Medicine, Shenyang Agricultural University, Shenyang, 110866, People's Republic of China.
Background:
Antibiotic resistance of many bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA), has become a major threat to global health. Zinc Oxide Quantum dots (ZnO-QDs) show good antibacterial activity, but most of them are insoluble in water, limiting their application range, and there is a lack of research on drug resistance inducement.
Methods:
The water-soluble zinc oxide quantum dots modified by APTES (ZnO@APTES QDs) were prepared by a microwave assisted synthesis. Then ZnO@APTES QDs were characterized through various methods. After confirmation of synthesized ZnO@APTES QDs, its bactericidal effect on MRSA was detected through in vitro and in vivo experiments, and its mechanism of action was analyzed.
Results:
Characterization analysis revealed that the ZnO@APTES QDs have a particle size of 5 nm. The minimum inhibitory concentrations (MIC) were determined to be 64 µg mL-1 for Escherichia coli (E. coli) and 32 µg mL-1 for MRSA. The ZnO@APTES QDs showed significant inhibition of MRSA biofilm formation and effectively disrupted mature biofilms. Notably, the ZnO@APTES QDs did not induce tolerance or resistance even after 30 days of repeated exposure, whereas antibiotics led to a rise in bacterial MIC within 3 days and a 60-fold increase after 30 days. Mechanistic analysis indicated that the positively charged quantum dots interact with bacterial surfaces, altering membrane fluidity. Once inside the bacteria, the ZnO@APTES QDs generate reactive oxygen species (ROS), causing DNA damage and bacterial cell death. Moreover, the ZnO@APTES QDs possessed good biocompatibility and demonstrated significant therapeutic efficacy against drug-resistant bacterial infections in both macrophage and mouse wound infection models.
Conclusion:
In summary, we have synthesized a highly effective water-soluble ZnO@APTES QDs that shows strong antibacterial and therapeutic efficacy against MRSA and other bacteria. The ZnO@APTES QDs holds significant potential for development as a new treatment agent for combating antibiotic-resistant infections.
Insights
Water-soluble zinc oxide quantum dots (ZnO-QDs) effectively combat antibiotic-resistant bacteria like MRSA without inducing resistance. These novel nanoparticles show significant therapeutic potential for treating drug-resistant infections.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- Antibiotic resistance, particularly Methicillin-resistant Staphylococcus aureus (MRSA), poses a significant global health challenge.
- Traditional zinc oxide quantum dots (ZnO-QDs) exhibit antibacterial properties but suffer from poor water solubility, limiting their therapeutic applications.
- Limited research exists on the potential of ZnO-QDs to induce drug resistance in bacteria.
Purpose of the Study:
- To synthesize water-soluble ZnO-QDs modified with APTES (ZnO@APTES QDs) using microwave-assisted synthesis.
- To characterize the synthesized ZnO@APTES QDs and evaluate their antibacterial activity against MRSA.
- To investigate the mechanism of action and assess the potential for inducing antibiotic resistance.
Main Methods:
- Microwave-assisted synthesis of APTES-modified ZnO quantum dots (ZnO@APTES QDs).
- Characterization of ZnO@APTES QDs using various analytical techniques.
- In vitro and in vivo assessment of bactericidal effects on MRSA, including biofilm inhibition and disruption.
- Evaluation of resistance induction potential over 30 days of repeated exposure.
- Mechanistic studies involving membrane fluidity analysis and reactive oxygen species (ROS) generation.
- Biocompatibility and therapeutic efficacy testing in macrophage and mouse wound infection models.
Main Results:
- Synthesized ZnO@APTES QDs possess a particle size of 5 nm and exhibit potent antibacterial activity, with minimum inhibitory concentrations (MIC) of 32 µg mL⁻¹ for MRSA and 64 µg mL⁻¹ for E. coli.
- ZnO@APTES QDs effectively inhibited MRSA biofilm formation and disrupted mature biofilms.
- Crucially, ZnO@APTES QDs did not induce bacterial tolerance or resistance after 30 days of repeated exposure, unlike conventional antibiotics which showed a significant increase in MIC.
- Mechanistic analysis revealed that ZnO@APTES QDs interact with bacterial membranes, generate ROS, damage DNA, and lead to cell death.
- The quantum dots demonstrated good biocompatibility and significant therapeutic efficacy in macrophage and mouse wound infection models.
Conclusions:
- Water-soluble ZnO@APTES QDs have been successfully synthesized and demonstrate potent antibacterial and therapeutic efficacy against MRSA and other bacteria.
- These novel ZnO@APTES QDs do not induce antibiotic resistance, offering a significant advantage over existing treatments.
- ZnO@APTES QDs hold substantial promise as a new therapeutic agent for combating challenging antibiotic-resistant infections.
More Related Videos
Related Concept Videos
01:24Microbial Corrosion
01:25Mechanism of Antibiotic Resistance in MRSA
01:25Clinical Significance of Antibiotic Resistance